Papillon Lefevre Disease
The use of chemotherapy in cancer treatment poses significant challenges. One major concern is the suppression of the immune system, especially leukocytes. This reduction heightens infection risks and impedes patient recovery. Sargramostim, a granulocyte-macrophage colony-stimulating factor, has shown promise in this context. This article examines its role in enhancing leukocyte recovery, thereby improving patient outcomes. […]
Papillon Lefevre Disease Read More »